Want to join the conversation?
$CSRA said its 3Q16 pro forma revenue was slightly below expectations, but was consistent with its 1H16 performance and down about 5% YoverY. Pro forma revenue in the first 3 quarters of FY16 have all been down 4-5% versus FY15. Adjusted EBITDA margin was above target range of 16-17%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?